The global minimally-invasive surgery devices market size was valued at USD 28.37 billion in 2021. It is projected to reach USD 53.04 billion by 2030, growing at a CAGR of 7.20% during the forecast period (2022-2030).
The phrase "minimally invasive" suggests that these surgeries are less invasive than alternative solutions. Using a knife to make incisions on a patient's body provided the surgeon with complete access to the body portion that required treatment decades ago. In addition to making the patient's recovery more challenging as they healed from a possibly colossal wound, doing this increased the patient's risk of contracting an infection. The rise in the frequency of chronic diseases linked to lifestyle choices and technical improvements that result in new product launches are some of the reasons contributing to the growth of the global market for minimally-invasive surgery devices.
People are becoming more interested in minimally invasive procedures in recent years instead of choosing open surgeries that need extensive muscle incisions. This is because muscle incisions from conventional procedures take a long time to heal. The main benefit of minimally invasive surgeries (MIS) over traditional open surgeries is higher precision because video-assisted equipment produces a better and magnified image of the organs or body parts. Additionally, one of the key reasons contributing to the market's expansion is the rising elderly population in the world. The need for managing various chronic disorders, such as those related to the gastrointestinal tract, is growing as the world's population ages quickly and becomes more susceptible to them due to advanced age. This increases the demand for minimally invasive procedures, such as laparoscopy.
Globally, the burden of chronic, lifestyle-related diseases such as diabetes, heart disease, cancer, gastrointestinal problems, and obesity is rising quickly. According to the World Health Organization's 2021 information sheet, diabetes, malignancies, and cardiovascular diseases account for most non-communicable disease (NCD) mortality, or 17.9 million people yearly (1.5 million). Additionally, nearly 80% of all premature NCD deaths worldwide are attributable to these four disease groups. The growth of these diseases is anticipated to drive market growth during the forecast period.
Compared to open surgery, minimally invasive procedures are performed by surgical specialists using advanced medical technology. Professionals with experience are required to perform these treatments. The principal minimally invasive surgery equipment users are surgical specialists, and there is a global lack of skilled medical personnel in many nations. Due to this shortage, patients who prefer a minimally invasive procedure must grudgingly undertake conventional operations.
This scarcity is especially severe in rural areas, where most healthcare facilities are state-owned. To improve the state of health in rural areas, the government is heavily sponsoring various programs. But the lack of skilled workers with the knowledge to use such devices prevents the minimally invasive devices category from taking advantage of this opportunity. Thus, it is anticipated that the factors mentioned above will limit the global minimally-invasive surgery devices market over the projected period.
Medical device producers must continue creating new items for use by doctors as the need for more sophisticated, minimally invasive procedures rises in response to new technology. Global operations help to drive up the sophistication of medical technology innovation rates. Manufacturers are creating items that could form the heart of future markets to deal with medical technology improvements and technologies that could support complex surgical operations with better patient outcomes. To create new products, manufacturers frequently invest time and money in research. They seek to enhance currently used items or procedures. Research and Development is the umbrella organization for these tasks (R&D). The market expansion is being fueled by several product releases and approvals that have occurred in recent years.
The global minimally-invasive surgery devices market is segmented by product type and application.
Based on Product Type, the global minimally-invasive surgery devices market is bifurcated into handheld instruments, guiding devices, electrosurgical devices, endoscopic devices, laparoscopic devices, monitoring and visualization devices, ablation devices, laser-based devices, robotic-assisted surgical systems, and others.
The endoscopic devices segment is the highest contributor to the market and is expected to grow at a CAGR of 7.25% during the forecast period. Endoscopes are minimally invasive instruments that can be put into the body's natural holes to examine an internal organ or tissue closely. For imaging treatments and simple surgeries, endoscopic surgery is used. Endoscopy may be necessary for several illnesses, including gastrointestinal problems, pancreatitis, stomach or esophageal cancer, respiratory tract problems, and urinary tract problems. The growing use of endoscopic operations for treating and diagnosing different diseases, technical improvements, and an increase in product introductions in recent years are projected to drive the market for endoscopic treatments.
Due to their benefits, such as fewer post-surgical issues, correct incision, no side effects after surgery, decreased blood loss, more straightforward healing, and shorter hospital stays, minimally invasive procedures are expected to see an increase in demand in the coming years. Some commonly used handheld equipment in different surgical operations include scalpels, forceps, scissors, cannulas, and retractors. These surgical tools are typically crafted from premium stainless steel and come in various designs, sizes, and shapes that are suitable for use. A cannula is a stick with a tubular construction used to remove contaminated bodily fluid. Additionally, a cannula is used during surgery to introduce the surgical instrument and to provide medication inside the body.
Based on Application, the global minimally-invasive surgery devices market is bifurcated into aesthetic, cardiovascular, gastrointestinal, orthopedic, urological, and gynecological.
The gastrointestinal segment owns the highest market share and is expected to grow at a CAGR of 7.40% during the forecast period. The demand for efficient diagnostic and treatment methods has increased due to the rising prevalence of gastrointestinal diseases like irritable bowel syndrome, gastroesophageal reflux disease, ulcers, gall bladder disease, and colorectal malignancies, projected to spur the study's expansion. According to GLOBOCAN predictions, there were 732,210 new cases of rectum cancer and 1,148,515 new cases of colon cancer worldwide in 2020. Due to the high incidence of colorectal cancer, there is an increasing need for endoscopy devices for minimally invasive procedures such as colonoscopy and sigmoidoscopy to screen for these tumors.
The aesthetic segment is anticipated to develop due to factors like an aging population, rising aesthetic procedure awareness, rising acceptance of minimally invasive devices, and technological advancements. Performing minimally invasive cosmetic operations is essential for enhancing one's appearance. Surgical and non-surgical procedures are also included in aesthetic procedures. Liposuction, breast implants, facelifts, and other associated surgeries are part of the surgical procedure. The growth of the aesthetic segment is therefore predicted to increase significantly during the projected period due to the considerations mentioned earlier.
The global minimally-invasive surgery devices market is divided into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
North America is the most significant shareholder in the global minimally-invasive surgery devices market and is anticipated to expand at a CAGR of 7.05% over the projection period. The development of the country's healthcare infrastructure, the rise in demand for minimally invasive surgeries, the presence of device manufacturers, the expansion of R&D activities that result in product launches, and better government initiatives to provide minimally invasive surgery devices are expected to boost the market. According to Globocan 2020, with 101,809 new cases, colon cancer was the fourth most prevalent cancer in the US in 2020. According to the same source, colon cancer accounted for almost 37,390 fatalities in the nation in 2020, making it the fourth most frequent cancer type to cause early death.
Europe is expected to grow at a CAGR of 6.80%, generating USD 13,831.91 million during the forecast period. The market for minimally invasive surgery equipment is expanding in Germany due to increased healthcare costs, increased use of minimally invasive procedures by healthcare facilities, improved infrastructure, and an increasing number of chronic diseases. Furthermore, it is anticipated that the presence of essential competitors will accelerate market expansion. According to a research article in the Budapest Business Journal in February 2021, one of Germany's biggest growing markets is the healthcare sector. There are 44 private and 112 governmental health insurance companies covering the health insurance needs of about 70 million individuals. There are 1,951 hospitals with 500,000 beds in the nation, which opens up a sizable market for the major firms to enter and grow their presence.
Asia-Pacific is anticipated to grow steadily during the forecast period. The Chinese market is driven by several important reasons, including an increase in surgical procedures, an aging population, a high burden of chronic diseases, and positive economic and demographic trends. According to the International Society of Aesthetic Plastic Surgery (ISAPS), there were approximately 3000 plastic surgeons in China as of 2019. There are likely to be more cosmetic surgeries performed in the nation as a result of the abundance of plastic surgeons. The majority of procedures are either entirely non-invasive or only slightly invasive; hence the cosmetic surgery industry is expected to grow quickly in the nation. According to the World Population Ageing 2019 research, the proportion of China's population 65 years of age or older was roughly 11.5% in 2019 and is projected to rise to 26.1% by 2050. The rising geriatric population is anticipated to boost market expansion since older people are more likely to undergo surgeries and other operations. The increase in the variety of procedures performed across the country is one of the key factors driving the demand for minimally invasive surgical equipment.
Despite being a developing nation, South Africa is one of the most technologically advanced nations. Non-communicable diseases (NCDs) are predicted to be responsible for 43% of all adult deaths in South Africa, with cardiovascular illnesses predicted to be responsible for over 19% of these deaths, according to the WHO 2018 study. Therefore, the growing elderly population is more likely to undergo surgery. Nigeria, Iran, Libya, Angola, Namibia, Egypt, Kenya, and Sudan are just a few of the nations in the Middle East and Africa's remaining countries. The Middle East and Africa (MEA) region's healthcare systems are under strain due to the region's rising population growth rate and the prevalence of lifestyle disorders.
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|